Introducing Sugammadex Sodium made by Medichem
Sugammadex Sodium is an injectable solution indicated for the reversal of neuromuscular blockade in anesthesia. Medichem is a vertically integrated manufacturer of the product, providing both the API and FDF. Our API plant in Malta offers our customers the competitive advantage of an early launch in countries without patent protection.
Medichem´s Sugammadex has been filed globally including in the USA (DMF in available for reference list), China (DMF filed and listed on CDE’s website) and Korea (DMF filed end of October 2020). In Europe, the DMF is already accepted and our 200 mg/2 ml and 500 mg/5 ml solutions for injection are approved in several countries through DCPs. Marketing Authorizations were granted in 2019.
For more information, please contact: email@example.com